Xaluprine

6-mercaptopurine monohydrate · Lipomed GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Xaluprine, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: EMA Authorised: Xaluprine (previously Mercaptopurine Nova Laboratories) (6-mercaptopurine monohydrate) — Lipomed GmbH